Wednesday 26 September 2012

Vertex ends work on one hepatitis C drug, continues another

BOSTON (Reuters) - Vertex Pharmaceuticals Inc said on Tuesday it will discontinue development of an experimental drug to treat hepatitis C after it failed to show sufficient efficacy. The company, which was developing the oral drug, known as ALS-2...

Source: http://health.yahoo.net/news/s/nm/vertex-ends-work-on-one-hepatitis-c-drug-continues-another

Grand Slam Troy Davis Eugene Murphy Jr. Libya

No comments:

Post a Comment

Note: only a member of this blog may post a comment.